- Quarterly equivalent
- $224.10/month; billed every 3 months
- Annual equivalent
- $199.20/month; billed every 12 months
- Supply details
- Confirm the prescribed quantity and concentration
The monthly plan is the clearest starting point
iThriveMD's rendered sermorelin page lists $249 for the option billed and shipped monthly. We use that amount in the comparison because it avoids mixing a month-to-month purchase with the lower equivalent attached to an annual commitment. The page describes the treatment as a subcutaneous injection prescribed and supervised by a licensed medical provider.
The listed price does not reveal the complete prescribed quantity or concentration. Those details, along with directions and storage requirements, need to match the dispensed product. We have not obtained a vial or completed the provider's clinical process, so this review assesses the public plan rather than a personally tested treatment.
Longer plans change the payment schedule
The three-month option displays $224.10 per month, the six-month option $211.65 and the twelve-month option $199.20. The accompanying labels say billing occurs every three, six or twelve months, respectively, while shipment remains monthly. That separation is central to understanding the offer.
Based on the posted equivalents, the corresponding period totals are $672.30, $1,269.90 and $2,390.40 before other charges. Confirm these calculations against the written quote and final payment screen. A monthly shipment should not be mistaken for permission to pay, cancel or recover unused funds one month at a time.
Define the care included in the amount
The provider describes a consultation, review of diagnostic information and continued monitoring. It advertises a free initial consultation. The page does not establish an itemized list of all laboratory, follow-up and pharmacy services included in each payment choice, so we leave the all-in total unverified.
Ask whether follow-up appointments, requested tests, shipping or supplies add charges and how a prescription change affects the price. Also confirm access in the relevant location, whether treatment would occur at home or in a clinic and which contact handles medical questions between scheduled reviews. Those details determine the usable care plan behind the number.
A wellness offer is not a diagnosis
iThriveMD associates sermorelin with changes in sleep, recovery, body composition and aging. These are the provider's claims, not outcomes established by this publication. Symptoms mentioned in marketing can have several explanations, and a general decline in hormone production with age does not by itself prove a treatment-requiring deficiency.
The Endocrine Society's adult growth-hormone-deficiency guideline emphasizes clinical evaluation and individualized decisions. Discuss what is being assessed and what evidence supports the actual proposed intervention. The guideline should not be presented as approval of this commercial plan or proof that its compounded injection will produce a particular result.
Keep regulatory and renewal questions visible
The provider refers to historical Geref approval, but current compounded preparations are not FDA-approved. The historical record and the status of this product therefore require separate descriptions. Pharmacy testing or facility credentials likewise do not replace evidence for the claimed clinical benefit.
Before selecting a discounted term, request its cancellation deadline, renewal amount and policy if treatment is stopped or changed. The monthly option is simpler to describe commercially; a longer plan may lower its equivalent rate but creates a larger commitment. Choose only after the clinical purpose, complete costs and exit conditions are clear.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.